$10,000 of HONEYWELL INTERNATIONAL INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Department of Defense research and procurement of various types of advanced armor materials, Defense Authorizations and Appropriations Bill inclusion."
You can find more data on corporate lobbying on Quiver Quantitative.
HON Congressional Stock Trading
Members of Congress have traded $HON stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $HON stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 09/25.
- SENATOR SHELDON WHITEHOUSE sold up to $50,000 on 09/04.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/17 and 1 sale worth up to $15,000 on 08/04.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
HON Hedge Fund Activity
We have seen 1,109 institutional investors add shares of HON stock to their portfolio, and 1,227 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BARCLAYS PLC removed 7,193,857 shares (-46.4%) from their portfolio in Q2 2025, for an estimated $1,675,305,418
- JPMORGAN CHASE & CO removed 7,093,809 shares (-42.2%) from their portfolio in Q2 2025, for an estimated $1,652,006,239
- CAPITAL WORLD INVESTORS added 5,963,520 shares (+65.0%) to their portfolio in Q2 2025, for an estimated $1,388,784,537
- CAPITAL RESEARCH GLOBAL INVESTORS removed 2,414,844 shares (-37.7%) from their portfolio in Q2 2025, for an estimated $562,368,870
- MACQUARIE GROUP LTD removed 1,405,864 shares (-87.1%) from their portfolio in Q2 2025, for an estimated $327,397,608
- CAPITAL INTERNATIONAL INVESTORS removed 950,840 shares (-43.3%) from their portfolio in Q2 2025, for an estimated $221,431,619
- BLACKROCK, INC. removed 923,953 shares (-2.0%) from their portfolio in Q2 2025, for an estimated $215,170,174
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HON Analyst Ratings
Wall Street analysts have issued reports on $HON in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 07/09/2025
- Citigroup issued a "Buy" rating on 06/04/2025
- Mizuho issued a "Outperform" rating on 05/16/2025
- B of A Securities issued a "Buy" rating on 05/07/2025
To track analyst ratings and price targets for HON, check out Quiver Quantitative's $HON forecast page.
HON Price Targets
Multiple analysts have issued price targets for $HON recently. We have seen 8 analysts offer price targets for $HON in the last 6 months, with a median target of $250.0.
Here are some recent targets:
- Joseph O'Dea from Wells Fargo set a target price of $220.0 on 10/06/2025
- Chris Snyder from Morgan Stanley set a target price of $245.0 on 07/28/2025
- Deane Dray from RBC Capital set a target price of $253.0 on 07/25/2025
- Julian Mitchell from Barclays set a target price of $265.0 on 07/09/2025
- Andrew Kaplowitz from Citigroup set a target price of $265.0 on 06/04/2025
- Stephen Tusa from JP Morgan set a target price of $217.0 on 05/16/2025
- Brett Linzey from Mizuho set a target price of $250.0 on 05/16/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
